Effects of platelet rich plasma on frozen embryo transfer process

Effeect of autologous platelet rich plasma on endometrial growth in frozen embryo transfer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110301005942N7

Enrollment

Registered

2018-12-07

Start date

2018-11-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, recurrent implantation failure. Complication associated with artificial fertilization, unspecified

Interventions

Intervention 1: Control group: . Intervention 2: Control group: .

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Body mass index (BMI) below 30 Inadequate endometrium (endometrial thickness below 7 mm) Failed embryo transfer

Exclusion criteria

Exclusion criteria: History of hematologic disorders Uterine abnormality (acquired or congenital) Unwillingness to continue

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.;Endometrial thickness. Timepoint: 48 hours after PRP. Method of measurement: Transvaginal ultrasound.	—

Secondary

Measure	Time frame
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAliye Ghasemzadeh

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 41 3553 9161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026